The severe consequences resulting from steatosis presence in CHC including increased risk of hepatic fibrosis and/or HCC, as well as decreased virologic response to antiviral therapy, all stress the urgency of investigating the complex derangements in host insulin and lipid metabolism. This evidence concerns the gene INS and hepatocellular carcinoma.